The Value Added Medicines Group Highlights the Importance of Access to Health during the CPhI Conference

3 October 2016

The Value Added Medicines Group a sector group of Medicines […]

Generic Medicines at the Heart of the French Public Health System

30 September 2016

Medicines for Europe strongly supports the French government campaign to […]

The global scourge of counterfeit medicines

29 September 2016

Generic Medicines save European Countries 100 Billion Euro per Year

28 September 2016

Lisbon, September 28, 2016 – Without the use of generic […]

Generic Medicines Increase Access to Treatments

27 September 2016

Medicines for Europe and GPhA commit to supporting positive developments of the negotiations for a TTIP

23 September 2016

   Medicines for Europe and GPhA (Generic Pharmaceutical Association) are committed to […]

UN Meeting on Antimicrobial Resistance (AMR): Medicines for Europe engaged in addressing the Global Threat of AMR

22 September 2016

As a signatory of the Davos Declaration we welcome the […]

Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market

19 September 2016

Biosimilar medicines provide a tremendous opportunity for governments throughout Europe […]

Pharma expert: new ‘value added medicines’ offer cheaper, customised treatment

26 July 2016

European biosimilar manufacturers want less discounts than for generics

20 July 2016

by Guillaume Bietry PARIS, July 20 (APM) – Generics and […]